Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
7.47
+0.08 (1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BHC stock have an average target of 7.25, with a low estimate of 3.00 and a high estimate of 11. The average target predicts a decrease of -2.95% from the current stock price of 7.47.
Analyst Consensus: Hold
* Price targets were last updated on Nov 1, 2024.
Analyst Ratings
The average analyst rating for BHC stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +47.26% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $8.5 | Hold | Maintains | $10 → $8.5 | +13.79% | Aug 2, 2024 |
| Piper Sandler | Piper Sandler | Hold → Sell Downgrades $9 → $3 | Hold → Sell | Downgrades | $9 → $3 | -59.84% | Aug 2, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -6.29% | Jul 25, 2024 |
| Raymond James | Raymond James | Hold Initiates $8 | Hold | Initiates | $8 | +7.10% | Jul 10, 2024 |
Financial Forecast
Revenue This Year
9.69B
from 8.76B
Increased by 10.68%
Revenue Next Year
10.05B
from 9.69B
Increased by 3.66%
EPS This Year
3.84
from -1.62
EPS Next Year
4.48
from 3.84
Increased by 16.76%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.1B | 10.6B | 11.0B | |||
| Avg | 9.7B | 10.0B | 10.3B | |||
| Low | 9.4B | 9.5B | 9.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 15.7% | 9.2% | 9.3% | |||
| Avg | 10.7% | 3.7% | 2.7% | |||
| Low | 6.8% | -1.8% | -2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 4.18 | 4.94 | 5.74 | |||
| Avg | 3.84 | 4.48 | 5.29 | |||
| Low | 3.63 | 4.11 | 4.90 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 28.6% | 28.1% | |||
| Avg | - | 16.8% | 18.0% | |||
| Low | - | 7.0% | 9.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.